By Benjamin Chiou
Date: Friday 16 Jan 2026
(Sharecast News) - Berenberg has raised its target price for Genus following the animal genetics group's first-half trading update on Friday, keeping the stock at a 'buy' citing "multiple catalysts" for the year ahead.
| Transaction in Own Shares | 16-Jan-2026 | 18:25 | RNS |
| Form 8.3 - Oxford Biomedica plc | 16-Jan-2026 | 15:20 | RNS |
| Aberforth Partners LLP - Form 8.3 - NCC Group plc | 16-Jan-2026 | 15:15 | PR Newswire |
| Form 8.3 - The Vanguard Group, Inc.: NCC Group plc | 16-Jan-2026 | 15:04 | EQS Group |
| Form 8.3 | 16-Jan-2026 | 14:28 | Business Wire |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Questor :Sage Group | 09-May-2014 | Telegraph |
| Price | 8,779.50 |
| Change Today | 144.30 |
| % Change | 1.67 % |
| 16-Jan-26 Close | 8,779.50 |
You are here: research